Analysts Viewpoint
SILO Pharma Inc’s latest rating changes from various analysts
In a filing, SILO Pharma Inc revealed its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on
Menu
In a filing, SILO Pharma Inc revealed its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
SILO Pharma Inc’s filing revealed that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on May
SILO Pharma Inc’s recent filing unveils that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. SILO Pharma
SILO Pharma Inc’s filing revealed that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on May